August 8, 2025Deleted Journal

Assessment of Bone Mineral Density Decline in Prostate Cancer Patients Undergoing Hormonal Therapy

View Full Paper

Ask AI

Bookmark

Prostate cancer patients on LHRH maintain higher bone mineral density compared to those on anti-androgen therapy.
Age, hormone therapy duration, BMI, and baseline BMD significantly affect bone density changes.
Analysis involved paired t-tests and linear regression using data from cancer patients' questionnaires.
Findings support the need for tailored hormonal therapies in managing bone health among prostate cancer patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Assessment shows differences in bone mineral density from hormonal treatments in prostate cancer patients, indicating therapy effects.

Sankaran et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark